These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4992359)

  • 1. Immunological control of Pseudomonas infection in burn patients: a clinical evaluation.
    Alexander JW; Fisher MW; MacMillan BG
    Arch Surg; 1971 Jan; 102(1):31-5. PubMed ID: 4992359
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of invasive pseudomonas infection in burns with a new vaccine.
    Alexander JW; Fisher MW; MacMillan BG; Altemeier WA
    Arch Surg; 1969 Aug; 99(2):249-56. PubMed ID: 4978523
    [No Abstract]   [Full Text] [Related]  

  • 3. Early protection by vaccines against Pseudomonas aeruginosa colonizing burns.
    Jones RJ; Lowbury EJ
    Br J Exp Pathol; 1972 Dec; 53(6):659-64. PubMed ID: 4630411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological control of pseudomonas infection in burns.
    R I Med J; 1972 Mar; 55(3):88. PubMed ID: 4622683
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoprophylaxis of Pseudomonas aeruginosa.
    Young LS; Armstrong D; Markley K
    Ann Intern Med; 1971 Jun; 74(6):1012-3. PubMed ID: 4996343
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of a vaccine for prevention of Pseudomonas aeruginosa infection of burn wounds in mice].
    Grochowski J; Bilinska M; Stankiewicz D; Arkusiewicz E
    Pol Przegl Chir; 1979 Jun; 51(6):623-7. PubMed ID: 116210
    [No Abstract]   [Full Text] [Related]  

  • 7. Control of infection following burn injury.
    Alexander JW
    Arch Surg; 1971 Oct; 103(4):435-41. PubMed ID: 5094548
    [No Abstract]   [Full Text] [Related]  

  • 8. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental burn wound sepsis: variations in response to topical agents.
    Krizek TJ; Cossman DV
    J Trauma; 1972 Jul; 12(7):553-62. PubMed ID: 4625533
    [No Abstract]   [Full Text] [Related]  

  • 10. Burn therapy--a current appraisal.
    Haynes BW
    Surg Annu; 1971; 3(0):125-47. PubMed ID: 4950708
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunization against Pseudomonas in infection after thermal injury.
    Wesley J; Fisher A; Fisher MW
    J Infect Dis; 1974 Nov; 130 Suppl(0):S152-8. PubMed ID: 4138646
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the effectiveness of antipseudomonas biological management in the control of infection in burn patients.
    Gonzáles Ayala SE; Daroda M; Villa J; Cecchini E; Vich J
    Panminerva Med; 1983; 25(3):203-8. PubMed ID: 6422426
    [No Abstract]   [Full Text] [Related]  

  • 13. [Is an active immunization against pseudomonas aeruginosa in burns justifiable?].
    Zellner PR; Zwissler O; Metzger E
    Chirurg; 1975 Oct; 46(10):462-66. PubMed ID: 815075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active and passive immunization against Pseudomonas aeruginosa infection of burned patients.
    Roe EA; Jones RJ
    Burns Incl Therm Inj; 1983 Jul; 9(6):433-9. PubMed ID: 6412970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of using a polyvalent vaccine against Pseudomonas aeruginosa in patients with burns treated at various therapeutic centers in Poland].
    Bukowska D; Serafińska D; Zietkiewicz W; Rudowski W; Hoffman S; Uszyński H; Molski M; Hess C; Jonecko A; Popiel D
    Pol Tyg Lek; 1986 Dec; 41(49):1549-52. PubMed ID: 3108869
    [No Abstract]   [Full Text] [Related]  

  • 16. Mafenide (Sulfamylon) and other topical agents for severe burns.
    Med Lett Drugs Ther; 1969 Aug; 11(17):69-70. PubMed ID: 5820567
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection by vaccination against Pseudomonas infection after thermal injury.
    Markley K; Smallman E
    J Bacteriol; 1968 Oct; 96(4):867-74. PubMed ID: 4971892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
    Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
    APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine prophylaxis for pseudomonas infections.
    Markley K
    Ann Intern Med; 1971 Jan; 74(1):140. PubMed ID: 4992650
    [No Abstract]   [Full Text] [Related]  

  • 20. Low mortality in burned patients in a Pseudomonas vaccine trial.
    Jones RJ; Roe EA; Gupta JL
    Lancet; 1978 Aug; 2(8086):401-3. PubMed ID: 79764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.